Individual and cumulative risk factors in developmental language disorder: A case-control study.

Preschool children case–control study child psychiatry clinical study cumulative risk developmental language disorder mental disorders risk factors

Journal

Clinical child psychology and psychiatry
ISSN: 1461-7021
Titre abrégé: Clin Child Psychol Psychiatry
Pays: England
ID NLM: 9604507

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 8 7 2022
medline: 1 2 2023
entrez: 7 7 2022
Statut: ppublish

Résumé

Many mental disorders (MD) share common etiology, fuelling debates about the specificity of clinical categories and whether the presence of specific risk factors (RF) can distinguish among them. The study of developmental language disorder (DLD), more specifically, has been further hindered by a lack of consensus regarding its definition. These limitations increase the risk of under-detection and lifelong consequences for affected children. This paper aims (1) to document which individual RF allow differentiating DLD from other MD and (2) to compare the cumulative RF between children with DLD versus other MD. This case-control design study used medical records of a psychiatric sample of 795 preschoolers (mean age 4:11, 75% boys). A logistic regression measured the predictive value of potential RF on DLD. Later first sentences, maternal immigration and family history of language delay were identified as significant in explaining 30% of the variance for DLD diagnosis. An ANCOVA revealed that children with DLD were exposed to a significantly higher number of RF than were children with other MD. Public health policies informed with the knowledge of specific RF associated with DLD, and their cumulative impact, could improve early detection and reduce the cascade of negative consequences associated with DLD.

Identifiants

pubmed: 35797616
doi: 10.1177/13591045221113389
pmc: PMC9893307
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

398-414

Références

Eur Arch Otorhinolaryngol. 2014 May;271(5):871-8
pubmed: 23715950
Am J Speech Lang Pathol. 2017 Aug 15;26(3):991-1010
pubmed: 28672377
Res Dev Disabil. 2020 Aug;103:103684
pubmed: 32454302
Int J Womens Health. 2021 Aug 10;13:751-759
pubmed: 34408501
Int J Lang Commun Disord. 2018 Mar;53(2):237-255
pubmed: 29139196
J Child Psychol Psychiatry. 2021 Apr;62(4):372-381
pubmed: 32433792
J Autism Dev Disord. 2018 Oct;48(10):3282-3295
pubmed: 29705923
PLoS One. 2016 Jul 08;11(7):e0158753
pubmed: 27392128
J Speech Lang Hear Res. 2017 Mar 1;60(3):607-626
pubmed: 28257586
Arch Intern Med. 1993 Sep 27;153(18):2093-101
pubmed: 8379800
MMWR Morb Mortal Wkly Rep. 2018 Dec 21;67(50):1377-1383
pubmed: 30571671
Brain Sci. 2021 May 17;11(5):
pubmed: 34067874
Pediatrics. 2010 Jul;126(1):e73-80
pubmed: 20587683
J Neural Transm (Vienna). 2008 Nov;115(11):1591-7
pubmed: 18818864
Child Care Health Dev. 2017 May;43(3):401-405
pubmed: 28321888
Semin Pediatr Neurol. 1997 Jun;4(2):70-6
pubmed: 9195663
Front Psychol. 2019 Jul 17;10:1586
pubmed: 31379654
J Pediatr. 2017 Feb;181:74-79.e3
pubmed: 27745750
Brain Sci. 2021 May 18;11(5):
pubmed: 34069813
Eur Child Adolesc Psychiatry. 2005 May;14(3):145-52
pubmed: 15959660
J Child Psychol Psychiatry. 2012 Jun;53(6):695-705
pubmed: 22211517
Neuropsychol Rev. 2012 Dec;22(4):384-401
pubmed: 22707315
J Child Psychol Psychiatry. 1991 Nov;32(7):1063-80
pubmed: 1787137
J Am Acad Child Adolesc Psychiatry. 2022 Feb;61(2):187-226
pubmed: 33864938
BMJ. 2013 Jan 15;346:e8687
pubmed: 23321410
Res Dev Disabil. 2013 Feb;34(2):756-63
pubmed: 23220052
Pediatr Clin North Am. 2018 Feb;65(1):13-29
pubmed: 29173713
J Child Psychol Psychiatry. 2016 Nov;57(11):1247-1257
pubmed: 27184709
J Child Psychol Psychiatry. 2017 Oct;58(10):1068-1080
pubmed: 28369935
JMIR Med Inform. 2021 Jun 8;9(6):e29242
pubmed: 33984830
J Autism Dev Disord. 2015 Aug;45(8):2361-72
pubmed: 25739693
PLoS One. 2015 Aug 04;10(8):e0134251
pubmed: 26241892

Auteurs

Florence Valade (F)

Department of Psychology, 5622University of Montreal, Montreal, QC, Canada.
CIUSSS Nord-de-l'Ile-de-Montréal, Hôpital en santé mentale Rivière-des-Prairies, Montreal, QC, Canada.

Marie-Julie Béliveau (MJ)

Department of Psychology, 5622University of Montreal, Montreal, QC, Canada.
CIUSSS Nord-de-l'Ile-de-Montréal, Hôpital en santé mentale Rivière-des-Prairies, Montreal, QC, Canada.

Chantale Breault (C)

CIUSSS Nord-de-l'Ile-de-Montréal, Hôpital en santé mentale Rivière-des-Prairies, Montreal, QC, Canada.
School of Speech-Language Pathology and Audiology, 5622University of Montreal, Montreal, QC, Canada.

Benjamin Chabot (B)

Department of Psychology, 5622University of Montreal, Montreal, QC, Canada.

Fannie Labelle (F)

Department of Psychology, 5622University of Montreal, Montreal, QC, Canada.
CIUSSS Nord-de-l'Ile-de-Montréal, Hôpital en santé mentale Rivière-des-Prairies, Montreal, QC, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH